University of Florida PhD students can apply to the T1D T32 by contacting Dr. Benjamin Keselowsky for application materials. The T32 Executive Committee will evaluate each applicant for academic standing and commitment to T1D research. Selected trainees will be appointed to the T32 beginning in August for a period of up to four years (contingent on satisfactory progress). Applicants must be US Citizens or permanent residents.
Alexander studies tolerogenic dual microparticle systems for treatment of multiple sclerosis, under the mentorship of Dr. Benjamin Keselowsky.
Leena utilizes single cell RNA-sequencing to perform immune profiling of NOD-CD226KO & human nPOD donor tissue, under the mentorship of Dr. Todd Brusko.
Matthew researches tolerogenic exosomes as a therapeutic for treating T1D, under the mentorship of Dr. Edward Phelps. He recently won an F Award from the NIH!
Mollie investigates T1D pathogenesis with the live pancreas tissue slice platform, under the mentorship of Dr. Mark Atkinson.
Magdalena engineers a dynamic three-dimensional in vitro platform for the investigation of human T1D immunopathogenesis
Anna studies exocrine pancreas metabolism in Type 1 Diabetes using a novel pancreas perfusion system under the mentorship of Dr. Matthew Merritt.
T1D T32 Fellows receive a biweekly stipend, set annually by the NIH, that coincides with UF’s payroll schedule. T32 Fellows also receive $1,000 annually for travel and professional development activities. As part of the T1D T32, Fellows must participate in the Immunology Journal Club, the Diabetes Data Club, T1D-relevant seminars at the Genetics Institute, and the Biomedical Engineering Seminar Series.